Reported Earnings • Aug 16
Second quarter 2026 earnings released: US$0.001 loss per share (vs US$0.021 loss in 2Q 2025) Second quarter 2026 results: US$0.001 loss per share (improved from US$0.021 loss in 2Q 2025). Net loss: US$39.3k (loss narrowed 86% from 2Q 2025). Reported Earnings • May 14
First quarter 2026 earnings released: US$0.028 loss per share (vs US$0.021 profit in 1Q 2025) First quarter 2026 results: US$0.028 loss per share (down from US$0.021 profit in 1Q 2025). Net loss: US$1.26m (down US$1.53m from profit in 1Q 2025). New Risk • Apr 07
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 46% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 90% per year over the past 5 years. Shareholders have been substantially diluted in the past year (46% increase in shares outstanding). Minor Risks Revenue is less than US$5m (US$3.0m revenue). Market cap is less than US$100m (US$77.0m market cap). Reported Earnings • Apr 04
Full year 2025 earnings released: US$0.27 loss per share (vs US$0.017 loss in FY 2024) Full year 2025 results: US$0.27 loss per share (further deteriorated from US$0.017 loss in FY 2024). Revenue: US$2.96m (down 10% from FY 2024). Net loss: US$3.68m (loss widened US$3.49m from FY 2024). New Risk • Mar 12
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 89% per year over the past 5 years. Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Revenue is less than US$5m (US$2.9m revenue). Market cap is less than US$100m (US$85.8m market cap). 공고 • Mar 12
Aureus Greenway Holdings Inc. announced that it has received $9.029001 million in funding from Unusual Machines, Inc., Rhone Group L.L.C. and other investors. On March 10, 2026, Aureus Greenway Holdings Inc. closed the transaction. The company issued 3,009,667 common shares and or pre funded warrants at an issue price of $3.00 per share or $3.00 per Pre-Funded Warrant, for gross proceeds of approximately $9,029,001 before deducting placement agent fees and other offering expenses. The transaction included participation from certain institutional and accredited investors, including Unusual Machines, Inc.and the Agostinelli Group. The Pre-Funded Warrants are immediately exercisable at a nominal exercise price of $0.001 per share, subject to adjustment, and will expire only when exercised in full, and are subject to customary beneficial ownership limitations and other terms and conditions set forth therein. In connection with the Private Placement, the Company also issued warrants to purchase a number of shares of Common Stock equal to 8.0% of the aggregate number of shares of Common Stock sold in the Private Placement (inclusive of shares underlying the Pre-Funded Warrants), at an exercise price of $3.00 per share, exercisable immediately upon issuance and expiring five years from the date of issuance, together with certain cash fees and expense reimbursements. The securities issued in the Private Placement were offered and sold in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), and Rule 506(b) of Regulation D promulgated thereunder, and have not been registered under the Securities Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from such registration requirements. The company paid a cash placement commission of 8.0% ($722,320.08) of the aggregate gross proceeds received in the Private Placement reasonable legal fees and disbursements of Placement Agent’s counsel of up to $125,000, as well as certain other customary offering expenses. 
